BONANNO, LAURA
BONANNO, LAURA
Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG
119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts)
2021 Dal Maso, A.; Pavan, A.; Ferro, A.; Pretelli, G.; Frega, S.; Menis, J.; Pasello, G.; Guarneri, V.; Conte, P. F.; Bonanno, L.
1398P Real-life progression (PD) pattern of EGFR mutant advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving systemic therapy after first- or second-generation tyrosine kinase inhibitor (1-2 gen TKI)
2020 Dal Maso, A.; Ferro, A.; Lorenzi, M.; Polo, V.; Scattolin, D.; Del Conte, A.; Scoccia, E.; Frega, S.; Bonanno, L.; Indraccolo, S.; Calabrese, F.; Guarneri, V.; Conte, P. F.; Pasello, G.
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW)
2021 Lorenzi, M.; Dal Maso, A.; Ferro, A.; Polo, V.; Scattolin, D.; Macerelli, M.; Follador, A.; Targato, G.; Indraccolo, S.; Frega, S.; Menis, J.; Bonanno, L.; Guarneri, V.; Conte, P. F.; Pasello, G.
166P: Non-small cell lung cancer (NSCLC) patients with rare or complex epidermal growth factor receptor (EGFR) mutations: A single institution series
2016 Pasello, G; Polo, V; Frega, Stefano; Lorenzi, M; Indraccolo, S; Fassan, Matteo; Bonanno, L; Nannini, N; Conte, Pierfranco; Calabrese, Fiorella
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy
2019 Evangelista, L.; Cuppari, L.; Menis, J.; Bonanno, L.; Reccia, P.; Frega, S.; Pasello, G.
211P: Inflammatory cells characterization and localization in malignant pleural mesothelioma (MPM) tissue samples: Correlation with histologic subtype and prognosis
2016 Urso, L; Polo, V; Bonanno, L; Nannini, N; Lunardi, F; Vuljan, S. E; Conte, P. F; Rea, Federico; Calabrese, Fiorella
28P Different genetic profiling in lung adenocarcinoma of smokers with and without chronic obstructive pulmonary disease (COPD): An exploratory analysis by next generation sequencing (NGS)
2016 Bonanno, L.; Schiavon, Marco; Lunardi, Francesca; Tebaldi, M.; Calistri, D.; Pasello, Giulia; Conte, Pierfranco; Rea, Federico; Indraccolo, Stefano; Calabrese, Fiorella
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features
2021 Bonanno, L.; Dal Maso, A.; Pavan, A.; Zulato, E.; Esposito, G.; Fassan, M.; Nardo, G.; Pasello, G.; Guarneri, V.; Calabrese, F.; Rea, F.; Indraccolo, S.; Conte, P. F.
77P Glycolytic marker monocarboxylate transporter 4 (MCT4) and outcome to bevacizumab (bev): An exploratory analysis in advanced non-small cell lung cancer (A-NSCLC)
2016 Bonanno, L; Calabrese, Fiorella; De Paoli, A; Pasello, G; Santo, A; Favaretto, A; Chilosi, M; Del Conte, A; Conte, P. F; Indraccolo, S.
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial
2017 Morabito, Alessandro; Daniele, Gennaro; Costanzo, Raffaele; Favaretto, Adolfo Gino; Filipazzi, Virgilio; Rossi, Antonio; Gebbia, Vittorio; Castiglione, Federico; Cavanna, Luigi; Maiello, Evaristo; Sandomenico, Claudia; Bonanno, Laura; Piazza, Elena; Maione, Paolo; Piccirillo, Maria Carmela; Di Maio, Massimo; Rocco, Gaetano; Gallo, Ciro; Perrone, Francesco; Gridelli, Cesare
A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case report.
2010 Pasello, G; Altavilla, G; Bonanno, L; Rea, Federico; Favaretto, Ag
A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer
2021 Wu, Yi-Long; Tsuboi, Masahiro; John, Thomas; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu-Vinh; Lu, Shun; Lee, Kye-Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Hodge, Rachel; Atasoy, Ajlan; Rukazenkov, Yuri; Herbst, Roy S
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations
2019 Passaro, Antonio; Prelaj, Arsela; Bonanno, Laura; Tiseo, Marcello; Tuzi, Alessandro; Proto, Claudia; Chiari, Rita; Rocco, Danilo; Genova, Carlo; Sini, Claudio; Cortinovis, Diego; Pilotto, Sara; Landi, Lorenza; Bennati, Chiara; Camerini, Andrea; Toschi, Luca; Putzu, Carlo; Cerea, Giulio; Spitaleri, Gianluca; Cappuzzo, Federico; de Marinis, Filippo
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial
2022 Piccirillo, Maria Carmela; Bonanno, Laura; Garassino, Marina Chiara; Esposito, Giovanna; Dazzi, Claudio; Cavanna, Luigi; Burgio, Marco Angelo; Rosetti, Francesco; Rizzato, Simona; Morgillo, Floriana; Cinieri, Saverio; Veccia, Antonello; Papi, Maximilan; Tonini, Giuseppe; Gebbia, Vittorio; Ricciardi, Serena; Pozzessere, Daniele; Ferro, Alessandra; Proto, Claudia; Costanzo, Raffaele; D'Arcangelo, Manolo; Proietto, Manuela; Gargiulo, Piera; Di Liello, Raimondo; Arenare, Laura; De Marinis, Filippo; Crinò, Lucio; Ciardiello, Fortunato; Normanno, Nicola; Gallo, Ciro; Perrone, Francesco; Gridelli, Cesare; Morabito, Alessandro
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non???Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
2023 Herbst, Roy S.; Wu, Yi-Long; John, Thomas; Grohe, Christian; Majem, Margarita; Wang, Jie; Kato, Terufumi; Goldman, Jonathan W.; Laktionov, Konstantin; Kim, Sang-We; Yu, Chong-Jen; Vinh Vu, Huu; Lu, Shun; Young Lee, Kye; Mukhametshina, Guzel; Akewanlop, Charuwan; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A.; Urban, Damien; Huang, Xiangning; Bolanos, Ana; Stachowiak, Marta; Tsuboi, Masahiro
Assessment of chromosomal rearrangements helps to differentiate multiple lung primary cancers from metastases
2019 Bonanno, Laura; Pavan, Alberto; Indraccolo, Stefano
Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature
2015 DI LISO, Elisabetta; Pennelli, Natale; Lodovichetti, Gigliola; Ghiotto, Cristina; Dei Tos, Angelo Paolo; Conte, Pierfranco; Bonanno, Laura
Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer
2018 Metro, Giulio; Passaro, Antonio; Lo Russo, Giuseppe; Bonanno, Laura; Giusti, Raffaele; Gregorc, Vanesa; Capelletto, Enrica; Martelli, Olga; Cecere, Fabiana L; Giannarelli, Diana; Luciani, Andrea; Bearz, Alessandra; Tuzi, Alessandro; Scotti, Vieri; Tonini, Giuseppe; Galetta, Domenico; Carta, Annamaria; Soto Parra, Hector; Rebonato, Alberto; Morabito, Alessandro; Chiari, Rita
Circulating biomarkers and risk of immune-related adverse events (irAEs) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and metastatic melanoma (mMel)
2019 Pavan, A.; Calvetti, L.; Dal Maso, A.; Fabozzi, A.; Piccin, L.; Chiarion-Sileni, V.; Pasello, G.; Aprile, G.; Guarneri, V.; Conte, P. F.; Bonanno, L.
Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC)
2022 Pasello, Giulia; Fabricio, Aline Sueli Coelho; Del Bianco, Paola; Favaretto, Adolfo; Salizzato, Valentina; Piccin, Luisa; Zustovich, Fable; De Rossi, Costanza; Pigozzo, Jacopo; Fabozzi, Alessio; Benetti, Beatrice; Tiozzo Fasiolo, Laura; Bonanno, Laura; Guarneri, Valentina; De Salvo, Gian Luca; Palleschi, Dario; Gion, Massimo; Chiarion-Sileni, Vanna